Compare Gilead Sciences, Inc. (GILD) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gilead Sciences, Inc. vs PPG Industries, Inc. — how do they compare? Gilead Sciences, Inc. trades at $147 (market cap $182.40B), while PPG Industries, Inc. trades at $105.43 (market cap $23.44B). The key difference: Gilead Sciences, Inc. is far larger — about 7.8× PPG Industries, Inc.'s market cap, and PPG Industries, Inc. pays the higher dividend (2.81%). Which is the better fit depends on your goals — on Pluang, investors hold Gilead Sciences, Inc. for 111 Days and PPG Industries, Inc. for 68 Days on average.
| GILD | PPG | |
|---|---|---|
Market Cap | $182.40B | $23.44B |
Volume | 4,469,821 | 2,064,777 |
Sector | Health | Basic Materials |
52-Week High | $155.80 | $131.56 |
52-Week Low | $116.74 | $94.34 |
Typical Hold Time | 111 Days | 68 Days |
Enterprise Value | $205.46B | $29.31B |
Dividend Yield | 2.23% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gilead Sciences (GILD) trades at $146.85, up 1.82% with bullish technical signals and strong analyst support. Recent earnings beat expectations in three consecutive quarters, though Q2 showed a significant loss. The company maintains robust operating cash flow of $10.02B (2025) and expanded HIV prevention access through a major PAHO partnership. Valuation metrics show a P/E of 17.84 and P/S of 6.02, with revenue growth from $29.44B (2025) to projected $30.5B (2026).
Outlook remains positive with 65% analyst buy ratings and $151.57 consensus target, though risks include negative net income margin (-10.64%) and high debt levels. The stock offers dividend income ($0.82 upcoming) and pipeline catalysts in oncology/HIV, but investors should monitor earnings volatility and competitive pressures in biopharma.
PPG Industries trades at $105.08, down 1.37% on the day, with technical indicators showing bearish momentum. The stock demonstrates solid fundamentals with a P/E of 15.08, net income margin of 9.57%, and strong cash flow generation of $1.94B from operations in 2025. Recent earnings show mixed results with Q1 2026 beating expectations but Q2 2026 missing estimates, while the company maintains its Dividend King status with consistent payouts.
The outlook remains cautiously optimistic with a $130 consensus price target representing 24% upside potential. Key risks include margin pressures in the Automotive Refinish segment and European demand weakness. Analyst consensus leans bullish with 55% buy ratings, though technical weakness suggests potential near-term consolidation before fundamental strength drives recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
